Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients

Sarath Kumar Jaganathan Jaishankar, Amrutha Murali, Amrin Marzooka

Open source

DOI
10.7860/jcdr/2020/42745.13488
Published
2020
Container
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Publisher
JCDR Research and Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7860/jcdr/2020/42745.13488,
  title = {Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients},
  author = {Sarath Kumar Jaganathan Jaishankar and Amrutha Murali and Amrin Marzooka},
  year = {2020},
  journal = {JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH},
  doi = {10.7860/jcdr/2020/42745.13488},
  url = {https://doi.org/10.7860/jcdr/2020/42745.13488}
}

RIS

TY  - JOUR
TI  - Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients
AU  - Sarath Kumar Jaganathan Jaishankar
AU  - Amrutha Murali
AU  - Amrin Marzooka
PY  - 2020
JO  - JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
DO  - 10.7860/jcdr/2020/42745.13488
UR  - https://doi.org/10.7860/jcdr/2020/42745.13488
ER  - 

APA

Jaishankar, S. K. J., Murali, A., & Marzooka, A. (2020). Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2020/42745.13488

Source records